文献速递肝胆胰外科

大肝癌腹腔镜肝切除:肿瘤大小对短期与长期结局的影响

Laparoscopic liver resection for large HCC: short- and long-term outcomes in relation to tumor size.
PubMed 文献 · Surg Endosc · 2018-05-16

该多中心回顾性研究纳入2003至2016年间172例接受腹腔镜肝切除的肝细胞癌患者,按肿瘤最大径分为<3 cm、3–5 cm和≥5 cm三组。结果显示大肝癌组转为开腹率更高、肝门阻断更频繁且时间更长、手术时间更长、出血更多、住院及ICU时间更长,但剔除大范围切除后除术后住院时间外差异消失;三组在并发症、死亡率、切除完整性和长期结局上无差异。

要点

  • 大肝癌(≥5 cm)腹腔镜肝切除的围术期负担更高,但并发症与长期肿瘤学结局与中小肝癌相当。
  • 大肝癌组大范围切除比例更高(31.6%),转为开腹率显著更高。
  • 剔除大范围切除病例后,除术后住院时间外围术期差异消失。

核心结论

  • 在高容量肝胆胰及腹腔镜中心,腹腔镜肝切除治疗肝细胞癌安全且肿瘤学有效,肿瘤大小除影响术后住院时间外不影响结局。

研究设计与样本

  • 多中心回顾性研究,纳入2003至2016年两家高容量肝脏手术中心的172例接受腹腔镜肝切除的肝细胞癌患者。
  • 按肿瘤最大径分为三组:组1 <3 cm(82例)、组2 3–5 cm(52例)、组3 ≥5 cm(38例),比较围术期与长期结局。

主要发现

  • 组1、组2、组3分别行小范围切除98.8%、90.4%、68.4%,大范围切除1.2%、9.6%、31.6%。
  • 剔除大范围切除病例后,上述差异除术后住院时间外均消失。
  • 三组在并发症、死亡率、切除完整性和长期结局方面无差异。
  • 后上段「技术性大范围」切除在组1、组2、组3分别为15.8%、19.2%、15.8%。

临床怎么用

  • 对于大肝癌(≥5 cm),在经验丰富的中心可考虑腹腔镜肝切除,但需预期更高的转开腹率、肝门阻断需求和更长住院时间。
  • 大范围切除可能是导致大肝癌围术期差异的主要因素,决策时需权衡切除范围。

局限性

  • 回顾性研究设计,样本量有限(172例),大肝癌组仅38例。
  • 结果来自两家高容量中心,外推至低容量中心需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In this study, we aim to assess the impact of tumor size on clinical and oncological outcomes in patients undergoing laparoscopic liver resection (LLR) for hepatocellular carcinoma (HCC). BACKGROUND: LLR has been shown to be feasible, safe, and oncologically efficient. However, it has been slow to develop in patients with HCC who often suffer from chronic liver disease which represents an additional challenge for the surgeon. The experience with large HCCs is even more limited. METHODS: Between 2003 and 2016, 172 patients from two high-volume liver surgery centers underwent LLR for HCC. Prospectively collected data were analyzed after stratification in 3 groups according to tumor major diameter (group 1: < 3 cm; group 2: between 3 and 5 cm; group 3: ≥ 5 cm). Perioperative and long-term outcomes were compared between the three groups and sub-analyses were carried out on the extent and location of the resections. RESULTS: Groups 1, 2, and 3 consisted of 82, 52, and 38 patients, respectively. Minor and major resections were performed in 98.8% and 1.2% in group 1, in 90.4% and 9.6% in group 2, and in 68.4% and 31.6% in group 3, respectively. Postero-superior "technically major" resections were performed in 15.8% patients in group 1, in 19.2% in group 2, and in 15.8% in group 3, respectively. Group 3 had higher conversion rates (p < 0.001), more frequent (p = 0.056) and more prolonged (p = 0,075) pedicle clamping and longer operative time (p < 0.001), higher blood losses (p = 0.025), and longer total hospital and intensive care unit stays. These differences ceased after removing the major resections from the study population, except for the postoperative length of stay. There were no differences in morbidity, mortality, completeness of resection rates, and long-term outcomes between the three groups. CONCLUSION: LLR for HCC appears to be safe and oncologically efficient when performed in high-volume HPB and laparoscopic centers. Tumor size does not appear to impact negatively on the outcomes except for postoperative hospital stay.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Levi Sandri GB, Spoletini G, Vennarecci G, et al. Laparoscopic liver resection for large HCC: short- and long-term outcomes in relation to tumor size. Surg Endosc. 2018. PMID: 29770883. doi:10.1007/s00464-018-6225-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。